News & Updates

Selective enoxaparin protocol lowers hematoma rates without compromising VTE protection

31 Jul 2024

A more selective risk-based approach to an enoxaparin thromboprophylaxis protocol appears to reduce the incidence of wound hematomas without increasing the rates of postpartum venous thromboembolism (VTE), as shown in a retrospective study.

Selective enoxaparin protocol lowers hematoma rates without compromising VTE protection

31 Jul 2024

RUBY update: Dostarlimab strengthens spot in the endometrial cancer treatment arena

30 Jul 2024 by

The addition of dostarlimab to a carboplatin-paclitaxel (CP) chemotherapy regimen confers an overall survival (OS) benefit in women with primary advanced or recurrent endometrial cancer (EC), according to the second interim analysis of the ENGOT-EN6/GOG-3031/RUBY trial part 1.

RUBY update: Dostarlimab strengthens spot in the endometrial cancer treatment arena

30 Jul 2024

Dual-function hydrogel implant helps stop endometriosis, pregnancy

29 Jul 2024 by

A novel, stimuli-responsive hydrogel implant for reversible occlusion of the fallopian tubes holds promise for preventing pregnancy and endometriosis or halting the latter’s spread, as reported in a study.

Dual-function hydrogel implant helps stop endometriosis, pregnancy

29 Jul 2024

Dual trigger as good as GnRHa alone trigger for mature oocyte retrieval

27 Jul 2024 by

Dual triggering with gonadotropin-releasing hormone agonist (GnRHa) and human chorionic gonadotropin (hCG) was not superior to GnRHa alone in terms of mature oocyte retrieval for elective fertility preservation, according to a study presented at ESHRE 2024.

Dual trigger as good as GnRHa alone trigger for mature oocyte retrieval

27 Jul 2024

Menopause linked to bladder woes

26 Jul 2024

Overactive bladder (OAB) is common among women undergoing menopause, especially among those at late menopausal stage and who have other menopausal symptoms, as reported in a cross-sectional study.

Menopause linked to bladder woes

26 Jul 2024

Air pollution detrimental to IVF success

26 Jul 2024 by

A study presented at ESHRE 2024 shows that increased exposure to fine particulate matter (PM2.5 and PM10) air pollution prior to oocyte collection (OPU) or frozen embryo transfer (FET) during in vitro fertilization (IVF) is associated with a reduction in live birth rates (LBRs) in subsequent FETs.

Air pollution detrimental to IVF success

26 Jul 2024

Endometrioma tied to ovarian cancer risk

26 Jul 2024

Women with ovarian endometriomas and/or deep infiltrating endometriosis are at increased risk of ovarian cancer, as shown in a study.

Endometrioma tied to ovarian cancer risk

26 Jul 2024

Novel pill keeps hopes up in infertile women ≤40 years undergoing IVF/ICSI

25 Jul 2024 by

In the phase II OXOART2 trial presented at ESHRE 2024, the first-in-class, non-hormonal, oral agent OXO-001 increases implantation and pregnancy rates in infertile women ≤40 years undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).

Novel pill keeps hopes up in infertile women ≤40 years undergoing IVF/ICSI

25 Jul 2024

Endometrial cancer in women under 40 years of age

24 Jul 2024 by

Endometrial cancer affects the lining of the uterus (ie, the endometrium). In Singapore, endometrial cancer is the most common gynaecological cancer, with an increasing incidence over the past few decades, corresponding to global trends associated with factors such as changing lifestyles, obesity, and hormonal influences.

Endometrial cancer in women under 40 years of age

24 Jul 2024

Weight trajectories across reproductive years up risk of adverse pregnancy outcomes

23 Jul 2024

Weight gains prior to and between pregnancies appear to increase the risk of adverse pregnancy outcomes (APOs), reports a study. A longer period of weight gain shows the most robust association with an increased risk of APOs.

Weight trajectories across reproductive years up risk of adverse pregnancy outcomes

23 Jul 2024

News & Updates

Filter by Specialty:

Specialty:

Selective enoxaparin protocol lowers hematoma rates without compromising VTE protection

Selective enoxaparin protocol lowers hematoma rates without compromising VTE protection

RUBY update: Dostarlimab strengthens spot in the endometrial cancer treatment arena

RUBY update: Dostarlimab strengthens spot in the endometrial cancer treatment arena

Dual-function hydrogel implant helps stop endometriosis, pregnancy

Dual-function hydrogel implant helps stop endometriosis, pregnancy

Dual trigger as good as GnRHa alone trigger for mature oocyte retrieval

Dual trigger as good as GnRHa alone trigger for mature oocyte retrieval

Menopause linked to bladder woes

Menopause linked to bladder woes

Air pollution detrimental to IVF success

Air pollution detrimental to IVF success

Endometrioma tied to ovarian cancer risk

Endometrioma tied to ovarian cancer risk

Novel pill keeps hopes up in infertile women ≤40 years undergoing IVF/ICSI

Novel pill keeps hopes up in infertile women ≤40 years undergoing IVF/ICSI

Endometrial cancer in women under 40 years of age

Endometrial cancer in women under 40 years of age

Weight trajectories across reproductive years up risk of adverse pregnancy outcomes

Weight trajectories across reproductive years up risk of adverse pregnancy outcomes